stock-detail (CLDX)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

Incyte Announces First Patient Treated in ECHO-301 Phase 3 Study

6/23/2016 10:05 am

(Yahoo! Finance) June 23, 2016 - Pivotal trial to evaluate epacadostat in combination with Keytruda® (pembrolizumab) as first-line treatment for patients with advanced or metastatic melanoma.

New Research Shows How Financial Engineering Could Make Life-Saving Drugs More Available And Affordable

2/25/2016 12:00 pm

(Dana-Farber) Feb 24, 2016 - Stratospheric costs for therapies not yet covered by insurance put some drugs out of reach for many patients. Securitized consumer healthcare loans could spread the cost of therapies over many years providing more patients access to the drugs.

CURE Media Group Launches Multiple Myeloma Heroes Awards Event to Honor Individuals Making Difference in Multiple Myeloma

2/9/2016 11:05 am

(PRWeb) Feb 8, 2016 - CURE Media Group, the nation’s leading digital and print media enterprise focused on cancer patients, has officially launched the Multiple Myeloma Heroes Awards event, which will annually honor individuals making heroic contributions in the field of multiple myeloma (MM) or in the lives of patients with MM.

Jimmy Carter to Discuss Cancer Diagnoses Thursday

8/19/2015 11:05 am

(CNN) Aug 18, 2015 - Former President Jimmy Carter has scheduled a Thursday morning news conference to discuss his cancer diagnosis.

AstraZeneca Announces New Gene Therapy Collaboration

8/3/2015 12:04 pm

(PharmaTimes [UK]) Aug 3, 2015 - AstraZeneca and Isis Pharmaceuticals will collaborate to develop antisense therapies for cardiovascular, metabolic and renal diseases.

Op-Ed: Should We Charge Patients for Medical Research?

8/3/2015 12:01 pm

(New York Times) July 31, 2015 - A few months ago, we got a call from a former oncology professor of ours.

ZAI Lab Announces A Global Licensing Agreement With Sanofi For A Novel Compound To Potentially Treat NSCLC

8/3/2015 12:01 pm

(ZAI Lab) July 31, 2015 - ZAI Lab Limited, an innovative biotech company based in China, announced today that it has entered into a global licensing agreement with Sanofi for a novel multi-kinase inhibitor for the potential treatment of non-small cell lung cancer and other oncology indications.

Amgen to Undergo Experimental Treatment

8/3/2015 12:00 pm

(Wall Street Journal) July 31, 2015 - The U.S. is about to experiment with biosimilars. Amgen, which reported solid second-quarter results Thursday, will play the role of guinea pig.

Opinion: Will Trans-Pacific Partnership Hold Back New Generic Drugs?

8/3/2015 11:05 am

(Los Angeles Times/Opinion L.A.) Aug 1, 2015 - The Times' editorial board, which has long supported free-trade deals, sounded a note of caution Friday about the next one in the pipeline, the Trans-Pacific Partnership.

AMA Wants Doctor Input on EHRs, Meaningful Use

8/3/2015 11:04 am

(Monthly Prescribing Reference/HealthDay News) July 31, 2015 - The American Medical Association is encouraging clinicians to share their perspectives on electronic heath records and the meaningful use program.

Bavarian Nordic Targeted by Short Seller’s Drug Critique

8/3/2015 11:03 am

(Bloomberg) Aug 3, 2015 - An investor that would benefit from a drop in Bavarian Nordic A/S shares issued a report saying that the Danish biotechnology company’s experimental prostate cancer vaccine will probably fail in late-stage testing.

BeiGene Receives Approval to Initiate Clinical Trials in China With BGB-283 for Solid Tumor Cancers

8/3/2015 11:02 am

(StreetInsider) Aug 3, 2015 - CTA approval received in China by BeiGene for a novel RAF dimer inhibitor that targets both B-RAF and K-RAS/N-RAS mutated cancers.

Swiss Drug Maker Roche Being Probed In Romania In Wide-Ranging Medical Corruption Case

8/3/2015 11:01 am

(Fox Business/Associated Press) July 31, 2015 - Swiss pharmaceuticals company Roche confirms it is being investigated by anti-corruption prosecutors looking for evidence that drug companies offered doctors vacations and other incentives in exchange for prescribing cancer drugs.

Samsung Electronics to Create Fund For Cancer-Stricken Workers, Safety

8/3/2015 11:01 am

(Reuters) Aug 3, 2015 - Tech giant Samsung Electronics Co Ltd said on Monday it will create a 100 billion won ($85.8 million) fund to compensate cancer-stricken workers and their families, and for efforts to prevent such diseases at its chip and display factories.

NCCN Seeking Poster Presentations From Nation's Top Oncology Researchers

8/3/2015 11:01 am

(NCCN) Aug 3, 2015 - NCCN is now accepting original abstracts from investigators for consideration for the NCCN 21st Annual Conference General Poster Session; the deadline for submissions is Friday, November 6, 2015.

Nominations Open for 2016 Pezcoller Foundation-AACR International Award for Cancer Research

8/3/2015 11:01 am

(AACR) July 31, 2015 - The American Association for Cancer Research (AACR) is accepting nominations for the 2016 Pezcoller Foundation-AACR International Award for Cancer Research.

Action Alert: Mesothelioma Bill in Congress for Patient Registry

8/3/2015 11:01 am

(The Meso Foundation/Cure Meso blog) July 29, 2015 - This bipartisan bill would establish the nation’s first formal federal registry to track mesothelioma patients.

Mattie Miracle Cancer Foundation Announces Completion Of Psychosocial Standards Of Care For Children With Cancer

8/3/2015 11:01 am

(Mattie Miracle Cancer Foundation) July 31, 2015 - Today, at the World Congress of Psycho-Oncology, leading researchers and clinicians dedicated to the psychosocial needs of children with cancer announced the completion of the Psychosocial Standards of Care to be published in a 2015 special issue of Pediatric Blood and Cancer.

Commentary: Practice-Changing Results From ASCO 2015: Immunotherapy in Previously Treated Advanced Non-Small Cell Lung Cancer

8/3/2015 11:00 am

(Medscape Medical News) July 31, 2015 - Dr. Jack West provides an analysis of practice-changing studies presented at ASCO 2015, with a focus on lung cancer.

Why Breast-Cancer Survivors Gain More Weight

7/15/2015 11:02 am

(TIME) July 15, 2015 - Tumors and treatment may make it easier to put on pounds, and the latest research shows why breast cancer patients should be aware of the dangers of gaining too much.

How the CMS Plans for ICD-10 Implementation Will Affect Hematologists

7/8/2015 11:05 am

(ASH) July 7, 2015 - The Centers for Medicare and Medicaid Services (CMS) has announced a new plan that will introduce some leniency in the introduction of the new ICD-10 diagnosis coding system.

The US Oncology Network Applauds Introduction of Medicare Patient Access to Treatment Act

6/30/2015 12:01 pm

(The US Oncology Network) June 25, 2015 – The US Oncology Network – one of the nation's largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care – today commended Representatives Mike Pompeo (R-KS) and Don Beyer (D-VA) for introducing the Medicare Patient Access to Treatment Act, legislation to level the playing field by creating a more adequate reimbursement structure for cancer care delivered in the community setting.

Mass. General’s Cancer Center Honors Dr. William Hait

5/26/2015 12:03 pm

(MyCentralJersey) May 24, 2015 - Dr. William N. Hait of Raritan, founder of Cancer Institute of New Jersey will be honored by Massachusetts General Hospital Cancer Center May 26.

Smoking May Make Return of Lung Cancer More Likely

5/20/2015 11:03 am

(Doctors Lounge/HealthDay News) May 19, 2015 - Lung cancer survivors are at high risk for recurrence of the disease, and smoking is a major factor in that risk, a new study shows.

ELCC 2015 News: VEGF SNPs Identified as Prognostic Markers for Bevacizumab Response in Patients with Advanced Non-Squamous NSCLC

4/16/2015 12:00 am

(ESMO) Apr 16, 2015 - Patients with advanced non-squamous non-small-cell lung cancer (NS-NSCLC) achieved median overall survival (OS) longer than one year in ANGIOMET, a prospective clinical trial of bevacizumab plus carboplatin and paclitaxel, leading the investigators to look for and identify biomarkers for this response.